CLASS II Drug recall · Reported 24 Nov 2021 · FDA Enforcement Report

Cartia XT (Diltiazem Hydrochloride Extended-Release recalled

Teva Pharmaceuticals USA is recalling Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, distributed nationwide in the US. The recall was initiated on 27 Oct 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 100023805, Exp. Date 05/2023

NDC62037-597, 62037-598, 62037-599, 62037-600

UPC0362037598906, 0362037599903, 0362037597909, 0362037600906

Quantity recalled32316 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number: D-0232-2022
FDA event ID: 88936
Recalling firm: Teva Pharmaceuticals USA, Parsippany, NJ
Brand: Cartia
Manufacturer: Actavis Pharma, Inc.
Classification: Class II
Status: Terminated
Recall initiated: 27 Oct 2021
FDA classified: 15 Nov 2021
Reported: 24 Nov 2021
Type: Voluntary: Firm initiated
Customers notified by: Letter
Reason category: Other Reasons
Drug class: Blood Pressure Medication

Timeline

27 Oct 2021	Recall initiated by company
15 Nov 2021	Classified by FDA	+19 days
24 Nov 2021	Published in enforcement report	+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labelling: Incorrect Exp. Date

Product as listed by the FDA

Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, Rx Only, 90 capsules, labelled as (a) Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054; (b) Manufactured By: Actavis Laboratories FL. Inc, Fort Lauderdale FL. 33314 USA, Distributed by Avista Pharma Inc. Parsippany, NJ 07054 USA. NDC 62037-597-90

Where it was distributed

Distributed Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Labelling: Incorrect Exp. Date

Which lots are affected?

Lot # 100023805, Exp. Date 05/2023

Where was it sold?

Distributed Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Teva Pharmaceuticals USA

All 280

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS II	traZODone Hydrochloride Tablets, USP, 50 mg recalledTrazodone Hydrochloride	Teva Pharmaceuticals USA	Other	Nationwide
13 May 2026Drug	CLASS II	Octreotide Acetate for Injectable Suspension recalledOctreotide Acetate	Teva Pharmaceuticals USA	Sterility	Nationwide
29 Apr 2026Drug	CLASS II	Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) recalledClaravis	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
15 Apr 2026Drug	CLASS II	Isotretinoin Capsules, USP, 30 mg recalled by Teva Pharmaceuticals USAIsotretinoin	Teva Pharmaceuticals USA	Potency & Assay	4 states
15 Apr 2026Drug	CLASS II	Isotretinoin Capsules, USP, 40 mg Prescription Pacs recalledIsotretinoin	Teva Pharmaceuticals USA	Potency & Assay	4 states

Other Diltiazem recalls

All 39

Reported	Class	Recall	Company	Reason	Where
16 Apr 2025Drug	CLASS II	Diltiazem Hydrochloride Extended-Release Capsules 12HR recalledDiltiazem Hydrochloride	Glenmark Pharmaceuticals Inc., USA	Manufacturing (CGMP) Deviations	Nationwide
11 Dec 2024Drug	CLASS II	Diltiazem Hydrochloride Extended-Release Capsules, USP 90 mg recalledDiltiazem Hydrochloride	Glenmark Pharmaceuticals Inc., USA	Nitrosamine Impurity	Nationwide
11 Dec 2024Drug	CLASS II	Diltiazem Hydrochloride Extended-Release Capsules recalled	Glenmark Pharmaceuticals Inc., USA	Nitrosamine Impurity	Nationwide
11 Dec 2024Drug	CLASS II	Diltiazem Hydrochloride Extended-Release Capsules recalledDiltiazem Hydrochloride	Glenmark Pharmaceuticals Inc., USA	Nitrosamine Impurity	Nationwide
11 Dec 2024Drug	CLASS II	Diltiazem Hydrochloride Extended-Release Capsules recalled	Glenmark Pharmaceuticals Inc., USA	Nitrosamine Impurity	Nationwide